Study on Biomarkers of Radiation-Induced Intestinal Injury
ConditionRadiation-induced Intestinal Injury
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTongji Hospital
About this trial
1. To identify biomarkers of radiation-induced intestinal injury; 2. To develop a predictive model for radiation-induced intestinal injury.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Abdominal radiotherapy dose ≥45 Gy;
Age ≥18 years;
Karnofsky Performance Status (KPS) >60;
Expected survival >6 months.
Disqualifiers
Prior history of abdominal radiotherapy;
Active intestinal infection;
Intestinal inflammatory diseases due to other causes;
Inability to provide biological samples.
Trial population
Patients with malignant tumors undergoing abdominal radiotherapy that may involve the intestine
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
220 Participants
are grouped into 1 trial groupGroup A: Patients with malignant tumors undergoing abdominal radiotherapy that may involve the intestine
Trial outcomes
Primary outcomes
1
Radiation-induced intestinal injury
Time frame
1 yearSecondary outcomes
1
overall survival
Time frame
5 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: